Thursday, June 24, 2021

admin

1204 POSTS2 COMMENTS

Merck Announces Phase 3 KEYNOTE-826 Trial Met Dual Primary Endpoints of OS and PFS

June 22, 2021: Merck known as MSD outside the United States and Canada announced that the pivotal Phase 3 KEYNOTE-826 trial investigating...

EU approve Koselugo for children with neurofibromatosis & plexiform neurofibromas

June 22, 2021: "AstraZenecaand MSD's Koselugo (selumetinib) has been granted conditional approval in the EU for the treatment of symptomatic, inoperable plexiform neurofibromas (PN)...

FDA Approves First Oral Blood Thinning Medication for Children

June 21, 2021: The U.S. FDA approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years...

Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA influenza vaccine

JUNE 22, 2021: "Sanofi Pasteur, the vaccines global business unit of Sanofi and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have...

Bayer and Zydus announce continuity of their successful Joint Venture

June 21, 2021: Bayer and Cadila Healthcare Limited announced the extension of their Joint Venture by three years from June 2021.

UN statement on renewal of humanitarian lifeline to millions of people in north-west Syria

June 18, 2021: "Millions of people are pressed up against the border in an active war zone in north-west Syria and remain in...

AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe

June 18, 2021: "AstraZeneca welcomed the ruling by the Court of First Instance in Brussels. The European Commission...

FDA Approves a Nasal Antihistamine for Non-prescription Use

June 17, 2021: "The U.S. FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription...

Lilly Launches Think Talk Treat Migraine™ to Help Improve Diagnosis and Treatment of Migraine

June 17, 2021: Based on results from a large population-based survey, it is estimated that approximately half of people with migraine hesitate...

CureVac’s COVID-19 vaccine CVnCoV misses the mark in late-stage study

June 16, 2021: "CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”) announced...

Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day Nurtec® ODT for the Preventive Treatment of Migraine

June 15, 2021: To advance the science of migraine treatment and aid the understanding of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs)...

Scientists develop ‘game-changing’ antibody test to detect new variants

June 15, 2021: Antibody tests that can detect whether people have been exposed to new variants of Covid-19 have been developed by...

TOP AUTHORS

1204 POSTS2 COMMENTS

Most Read

Merck Announces Phase 3 KEYNOTE-826 Trial Met Dual Primary Endpoints of OS and PFS

June 22, 2021: Merck known as MSD outside the United States and Canada announced that the pivotal Phase 3 KEYNOTE-826 trial investigating...

EU approve Koselugo for children with neurofibromatosis & plexiform neurofibromas

June 22, 2021: "AstraZenecaand MSD's Koselugo (selumetinib) has been granted conditional approval in the EU for the treatment of symptomatic, inoperable plexiform neurofibromas (PN)...

FDA Approves First Oral Blood Thinning Medication for Children

June 21, 2021: The U.S. FDA approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years...

Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA influenza vaccine

JUNE 22, 2021: "Sanofi Pasteur, the vaccines global business unit of Sanofi and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have...